CRAC inhibitor (TPP Global Development)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCRAC inhibitor (TPP Global Development)
Drug Alias NameCRAC inhibitor (TPP Global Development)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium release activated calcium channels inhibitors
TargetsCalcium release activated calcium channels
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIomet Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIomet Pharma Ltd
Active IndicationsN/A
Inactive IndicationsImmunologic Deficiency Syndromes

Other Information

ATC CodeN/A
Related LinksN/A